← Leaderboards
Michael S Breen
Icahn School Of Medicine At Mount Sinai
$1,925,499
Attributed
$1,925,499
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $741.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,925,499 · 3
By mechanism
R01$1,125,845 · 1
R21$464,414 · 1
R03$335,240 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Balaji Manicassamy$10,074,679
- Daniela Schiller$4,002,684
- Robert H Pietrzak$9,130,471
- Ernesto Guccione$11,143,318
- Zachary Thomas Pennington$321,506
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMolecularSiteTranscriptomeBiologicalCell TypeGenome-WideRegulationEtiologyTranscriptomicsGene ExpressionBindingGeneticAlternative SplicingBaseGenesGenetic DiseasesDouble-Stranded RnaDementiaAdenosineBrainBrain CellDisorder RiskDsrna Adenosine Deaminase
Grant awards (6)
Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease$553,277
R01 · FY2025 · AG · contact PI
Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease$572,568
R01 · FY2024 · AG · contact PI
Integrative genomic analysis of adenosine-to-inosine editing in Alzheimer's disease$169,000
R03 · FY2024 · AG · contact PI
Integrative genomic analysis of adenosine-to-inosine editing in Alzheimer's disease$166,240
R03 · FY2023 · AG · contact PI
Development of a diagnostic platform for PTSD blood biomarkers$211,250
R21 · FY2022 · MH · contact PI
Development of a diagnostic platform for PTSD blood biomarkers$253,164
R21 · FY2021 · MH · contact PI